Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

clinical trials

Why Patient Dropout Rates Are Rising in Clinical Research
Posted in
  • Case Studies & Trends

Why Patient Dropout Rates Are Rising in Clinical Research

Patient retention is a critical factor in the success of clinical trials, yet dropout rates have … Why Patient Dropout Rates Are Rising in Clinical ResearchRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
Why Clinical Trial Sites Are Burned Out and What Pharma Can Do
Posted in
  • Case Studies & Trends

Why Clinical Trial Sites Are Burned Out and What Pharma Can Do

Clinical trial sites in the United States are under mounting pressure, with recent surveys showing that … Why Clinical Trial Sites Are Burned Out and What Pharma Can DoRead more

by Jayshree Gondane•March 12, 2026March 12, 2026•0
How Better Trial Recruitment Shortens Time to Market
Posted in
  • Digital Transformation

How Better Trial Recruitment Shortens Time to Market

Efficient patient recruitment is one of the most critical factors in accelerating clinical trials and bringing … How Better Trial Recruitment Shortens Time to MarketRead more

by Jayshree Gondane•March 12, 2026•0
Why Clinical Trials Need Better Patient Communication
Posted in
  • Industry Landscape

Why Clinical Trials Need Better Patient Communication

Clinical trials are the foundation of modern drug development. Before a new therapy can reach patients, … Why Clinical Trials Need Better Patient CommunicationRead more

by Jayshree Gondane•March 11, 2026March 11, 2026•0
How Clinical Trial Technology Can Reduce Costs in the U.S. Pharmaceutical Industry
Posted in
  • Digital Transformation

How Clinical Trial Technology Can Reduce Costs in the U.S. Pharmaceutical Industry

The rising cost of drug development in the United States has become a significant challenge for … How Clinical Trial Technology Can Reduce Costs in the U.S. Pharmaceutical IndustryRead more

by Jayshree Gondane•March 11, 2026March 11, 2026•0
Why Clinical Trial Complexity Keeps Increasing
Posted in
  • Industry Landscape

Why Clinical Trial Complexity Keeps Increasing

Clinical trials have always been central to pharmaceutical innovation. They provide the scientific evidence regulators require … Why Clinical Trial Complexity Keeps IncreasingRead more

by Jayshree Gondane•March 7, 2026March 7, 2026•0
Why Many Clinical Trials Fail to Reflect Real Patients
Posted in
  • Industry Landscape

Why Many Clinical Trials Fail to Reflect Real Patients

Clinical trials are the backbone of pharmaceutical development, providing the critical data required for regulatory approval … Why Many Clinical Trials Fail to Reflect Real PatientsRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0
How Pharma Companies Can Reduce Clinical Trial Dropouts
Posted in
  • Strategy & Execution

How Pharma Companies Can Reduce Clinical Trial Dropouts

Clinical trials represent one of the most complex and resource-intensive phases of pharmaceutical development. Before a … How Pharma Companies Can Reduce Clinical Trial DropoutsRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0
Why Early Market Research Can Prevent Clinical Trial Failure in the U.S. Pharmaceutical Industry
Posted in
  • Strategy & Execution

Why Early Market Research Can Prevent Clinical Trial Failure in the U.S. Pharmaceutical Industry

Clinical trial failure remains one of the most expensive risks in pharmaceutical development. Drug companies invest … Why Early Market Research Can Prevent Clinical Trial Failure in the U.S. Pharmaceutical IndustryRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0
How Clinical Trial Delays Affect Investor Confidence
Posted in
  • Industry Landscape

How Clinical Trial Delays Affect Investor Confidence

Clinical trials represent the most critical and expensive stage in pharmaceutical development. Before a new therapy … How Clinical Trial Delays Affect Investor ConfidenceRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0

Posts pagination

1 2 Next

Recent Posts

  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy
  • FDA Draft Guidance on AI in Pharmaceutical Advertising: What Pharma Marketers Must Know Now
  • The Uncomfortable Truth About Pharmaceutical Marketing Failure
  • The Truth About Pharmaceutical Marketing in the United States

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A